CBT vs CGAU
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Cabot Corporation presents a stable but stagnating profile, evidenced by a Piotroski F-Score of 4/9. While the company maintains strong profitability with an ROE of 21.82% and a consistent track record of earnings beats, it is currently facing significant headwinds with negative YoY revenue (-11.10%) and earnings growth (-18.20%). The stock is trading at a significant premium to both its Graham Number ($62.31) and Intrinsic Value ($40.04), suggesting limited upside potential at current price levels.
CGAU presents a stark contrast between exceptional valuation and deteriorating fundamental trends. While the stock is significantly undervalued relative to its Graham Number ($25.67) and Intrinsic Value ($19.88), the Piotroski F-Score of 3/9 indicates weak financial health and negative operational trends. Despite a near-zero debt profile and high profitability, the bearish technical trend (10/100) and an analyst target price ($17.75) below the current market price suggest immediate headwinds.
Compare Another Pair
Related Comparisons
CBT vs CGAU: Head-to-Head Comparison
This page compares Cabot Corporation (CBT) and Centerra Gold Inc. (CGAU) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.